Möchten Sie immer auf dem neuesten Stand bleiben?

New York, USA, June 24, 2025 (GLOBE NEWSWIRE) -- Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight Multiple Sclerosis, the...

New York, USA, June 19, 2025 (GLOBE NEWSWIRE) -- Urea Cycle Disorders Market to Register Sustainable Growth During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s...

New York, USA, June 19, 2025 (GLOBE NEWSWIRE) -- Global Protein Expression Market to Observe Growth at a CAGR of ~8% by 2032 | DelveInsight The protein expression market is primarily driven by the...

New York, USA, June 19, 2025 (GLOBE NEWSWIRE) -- Dermatomyositis Market Set to Witness Significant Growth During the Study Period (2020–2034) Amid Rising Awareness and Advanced Treatments |...

New York, USA, June 18, 2025 (GLOBE NEWSWIRE) -- Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight The global surge in...

New York, USA, June 17, 2025 (GLOBE NEWSWIRE) -- Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...

New York, USA, June 16, 2025 (GLOBE NEWSWIRE) -- Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types According to DelveInsight’s analysis, the...

New York, USA, June 12, 2025 (GLOBE NEWSWIRE) -- Global Uterine Fibroids Treatment Devices Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2032 | DelveInsight The growing...

New York, USA, June 12, 2025 (GLOBE NEWSWIRE) -- Giant-cell Arteritis Market Heats up with AbbVie’s RINVOQ Approval | DelveInsight The FDA has approved AbbVie’s RINVOQ (upadacitinib) for the...

New York, USA, June 11, 2025 (GLOBE NEWSWIRE) -- Global Electronic Health Record Market is Projected to Reach ~USD 54 Billion by 2032 | DelveInsight The electronic health records market is...